Advancing Early Detection of Alzheimer Disease in the Primary Care Setting in the United States
Primary care physicians are willing to adopt blood-based biomarker tests for diagnosing MCI and mild dementia due to AD, provided that they receive enhanced education, clear guidelines, and reimbursement support.
Authors
- Yan Hu (ORCID: https://orcid.org/0000-0003-3269-4505)
- Monica W. Parker (ORCID: https://orcid.org/0000-0002-7596-9831)
- Harald Hampel (ORCID: https://orcid.org/0000-0003-0894-8982)
- Jonathan Liss
- Min Cho (ORCID: https://orcid.org/0000-0003-4696-0173)
- Steven R. Smith (ORCID: https://orcid.org/0000-0002-5098-8147)
- Jeffrey Murray Burns (ORCID: https://orcid.org/0000-0001-7609-8954)
- Thomas O. Obisesan (ORCID: https://orcid.org/0000-0002-0291-512X)
- Michelle M. Mielke (ORCID: https://orcid.org/0000-0001-7177-1185)
- Michael Hornbecker
- Arnold Pallay
- Joanne Bell
- Lawrence S. Honig
- H. Ricky Kurzman
Institutions
- Howard University (US)
- Columbia University Irving Medical Center (US)
- AdventHealth Orlando (US)
- Alzheimer’s Disease Neuroimaging Initiative (US)
- Columbus Center (US)
- Wake Forest University (US)
- Eisai (Japan) (JP)
- Atlantic Health System (US)
Publication Details
- Journal
- Neurology Clinical Practice
- Published
- 2025-12-22
- DOI
- https://doi.org/10.1212/cpj.0000000000200568
- Citations
- 1
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 1.47